Effectiveness and Safety of Novel Nutraceutical Formulation Added to Ezetimibe in Statin-Intolerant Hypercholesterolemic Subjects with Moderate-to-High Cardiovascular Risk-Reference-Cited by-同舟云学术

Effectiveness and Safety of Novel Nutraceutical Formulation Added to Ezetimibe in Statin-Intolerant Hypercholesterolemic Subjects with Moderate-to-High Cardiovascular Risk

Published:2021-01-01 Issue:1 Volume:24 Page:59-66
ISSN:1096-620X
Container-title:Journal of Medicinal Food
language:en
Short-container-title:Journal of Medicinal Food

Author:

Mazza Alberto¹²,Nicoletti Mariaceleste³,Lenti Salvatore⁴,Torin Gioia⁵,Rigatelli Gianluca⁶,Pellizzato Marzia⁷,Fratter Andrea⁷

Affiliation:

1. ESH Excellence Hypertension Centre, Internal Medicine Unit, Santa Maria della Misericordia General Hospital, Rovigo, Italy.

2. Italian Nutraceutical Society (SINut), Triveneto Area, Rovigo, Italy.

3. Krea Innovazione srl, Milano, Italy.

4. Hypertension Centre and Internal Medicine and Geriatrics, San Donato Hospital, Arezzo, Italy.

5. Internal Medicine Unit, Department of Medicine, Santa Maria della Misericordia General Hospital, Rovigo, Italy.

6. Interventional Cardiology Unit, Division of Cardiology, S. Maria della Misericordia General Hospital, Rovigo, Italy.

7. Italian Society of Nutraceutical Formulators (SIFNUT), Treviso, Italy.

Publisher

Mary Ann Liebert Inc

Subject

Nutrition and Dietetics,Medicine (miscellaneous)

Link

https://www.liebertpub.com/doi/pdf/10.1089/jmf.2020.0019

Reference56 articles.

1. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

2. Adverse Effects of Statins - Myths and Reality

3. Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

4. Statin-Associated Myopathy

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sickle Cell Anemia Its Epidemiology, Pathophysiology, Nutraceuticals Role: A Review;Journal for Research in Applied Sciences and Biotechnology;2024-09-01

2. Quercetin as a possible cardiovascular agent;Quercetin - Effects on Human Health [Working Title];2023-11-21

3. Impact of Berberine or Berberine Combination Products on Lipoprotein, Triglyceride and Biological Safety Marker Concentrations in Patients with Hyperlipidemia: A Systematic Review and Meta-Analysis;Journal of Dietary Supplements;2023-05-14

4. Nutracéuticos (monacolina K, berberina y coenzima Q10) en pacientes con hipercolesterolemia moderada y un riesgo cardiovascular bajo-moderado. Potenciales beneficios de los tratamientos combinados;Medicina de Familia. SEMERGEN;2023-03

5. A Comprehensive Review on Nutraceuticals: Therapy Support and Formulation Challenges;Nutrients;2022-11-03